PAA 0.00% 19.0¢ pharmaust limited

& that’s why it hit us$2.4b when it listed. Clearly we don’t...

  1. 1,083 Posts.
    lightbulb Created with Sketch. 92
    & that’s why it hit us$2.4b when it listed. Clearly we don’t have approval yet, but things look promising. Even after allowing for some dilution, that would imply a$6.6 per share, on ALS only.

    So I largely agree with Kron, we can easily creep higher as events unfold pre phase 2 trial readout.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.